This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1988.
Company Filing History:
1 out of 834,307 Years Active: 1988
Title: John C Boothroyd: Innovator in Recombinant DNA Technology
Introduction
John C Boothroyd is a notable inventor based in Beckenham, Kent, GB. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant DNA technology. His work has implications for vaccine development, specifically targeting foot and mouth disease.
Latest Patents
Boothroyd holds a patent for a recombinant DNA expression vector encoding for foot and mouth disease. This patent describes a DNA molecule that comprises a nucleotide sequence substantially corresponding to all or a portion of foot and mouth disease virus RNA. It specifically codes for at least one protein of the foot and mouth disease virus. The DNA molecule can be inserted into a DNA cloning vehicle capable of expressing the DNA molecule after a suitable host cell has been transformed by the cloning vehicle. The expression product can be incorporated into a vaccine for stimulating antibodies against FMDV. The patent also details methods for producing the DNA molecule, recombinant cloning vehicle, and transformed host cell.
Career Highlights
Throughout his career, Boothroyd has focused on advancing the understanding and application of recombinant DNA technology. His innovative approaches have paved the way for new methods in vaccine development, contributing to public health initiatives.
Collaborations
Boothroyd has collaborated with esteemed colleagues in his field, including George A Cross and Michael D Highfield. These partnerships have enhanced the scope and impact of his research.
Conclusion
John C Boothroyd's contributions to recombinant DNA technology and vaccine development highlight his role as a key innovator in biotechnology. His work continues to influence advancements in the fight against infectious diseases.